NCT07152145Not yet recruiting
Pilot Study of tSCS for Improving Upper Limb Function in People With Multiple Sclerosis
Transcutaneous Electrical Spinal Stimulation (tSCS) for Improving Upper Limb Function in People With MS
Source: ClinicalTrials.gov · Last updated 3 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate whether non-invasive spinal cord neuromodulation with the SCONE™ device can improve upper limb function in people with multiple sclerosis. The study will investigate if combining SCONE™ therapy with rehabilitation exercises leads to improvements in arm and hand movement, and whether the therapy is safe and well tolerated in this patient population. Participants will receive non-invasive spinal cord stimulation with the SCONE™ device and perform rehabilitation exercises specifically focused on the upper limb.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 22 Aug 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Parc de Salut Mar
- Diseases
- Multiple sclerosis
- NCT number
- NCT07152145
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Oct 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Relapse or corticosteroid treatment within the last 3 months.
Other illness
- Epilepsy or uncontrolled seizures.
- Severe psychiatric disorders or cognitive impairment interfering with study procedures.
Other
- Severe spasticity of the upper limb (Modified Ashworth Scale \> 3).
- Implanted electrical devices (pacemaker, spinal cord stimulator).
- Pregnant or breastfeeding women.
- Participation in another interventional clinical trial within the last 3 months.
Who the study is looking for
- Age between 18 and 70 years.
- Diagnosis of Multiple Sclerosis (according to revised McDonald criteria).
- Upper limb dysfunction (9-Hole Peg Test score ≥ 20% slower than normative values).
- Stable disease-modifying treatment for ≥ 6 months before enrollment.
- Expanded Disability Status Scale (EDSS) score between 3.0 and 6.5.
- Ability to provide informed consent.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital del Mar Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.